Twist Bioscience Corporation
Twist Bioscience Corporation (TWST) Stock Overview
Explore Twist Bioscience Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.9B
P/E Ratio
-38.14
EPS (TTM)
$-1.27
ROE
-0.17%
TWST Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Twist Bioscience Corporation (TWST) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $37.90.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -38.14 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.